Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4527597
Max Phase: Preclinical
Molecular Formula: C21H19N5O
Molecular Weight: 357.42
Molecule Type: Unknown
Associated Items:
ID: ALA4527597
Max Phase: Preclinical
Molecular Formula: C21H19N5O
Molecular Weight: 357.42
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Nc1n[nH]c(NCc2ccccc2Oc2ccc(-c3ccccc3)cc2)n1
Standard InChI: InChI=1S/C21H19N5O/c22-20-24-21(26-25-20)23-14-17-8-4-5-9-19(17)27-18-12-10-16(11-13-18)15-6-2-1-3-7-15/h1-13H,14H2,(H4,22,23,24,25,26)
Standard InChI Key: DPANAEUYJBVMOZ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 357.42 | Molecular Weight (Monoisotopic): 357.1590 | AlogP: 4.46 | #Rotatable Bonds: 6 |
Polar Surface Area: 88.85 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.51 | CX Basic pKa: 3.79 | CX LogP: 4.47 | CX LogD: 4.47 |
Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.47 | Np Likeness Score: -0.97 |
1. Holshouser S, Dunworth M, Murray-Stewart T, Peterson YK, Burger P, Kirkpatrick J, Chen HH, Casero RA, Woster PM.. (2019) Dual inhibitors of LSD1 and spermine oxidase., 10 (5): [PMID:31191868] [10.1039/C8MD00610E] |
Source(1):